Vertex Pharmaceuticals (VRTX) Market Capitalization (2009 - 2026)

Vertex Pharmaceuticals has reported Market Capitalization for 18 years, with the latest figure at $125.8 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 10.29% year-over-year to $125.8 billion in Q2 2026; TTM through Jun 2026 was $125.8 billion, a 10.29% increase from a year earlier, with the FY2025 full-year figure at $115.1 billion, up 11.29% from the prior year.
• Market Capitalization was $125.8 billion for Q2 2026 at Vertex Pharmaceuticals, up from $113.5 billion in the prior quarter.
• The five-year high for Market Capitalization was $125.8 billion in Q2 2026, with the low at $66.7 billion in Q1 2022.
• Average Market Capitalization over 5 years is $99.9 billion, with a median of $104.2 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization surged 59.9% in 2022, then dropped 17.03% in 2025.
• Over 5 years, Market Capitalization stood at $74.2 billion in 2022, then surged by 41.27% to $104.9 billion in 2023, then slipped by 1.32% to $103.5 billion in 2024, then climbed by 11.29% to $115.1 billion in 2025, then climbed by 9.29% to $125.8 billion in 2026.
• The last three Market Capitalization figures came in at $125.8 billion (Q2 2026), $113.5 billion (Q1 2026), and $115.1 billion (Q4 2025), per Business Quant data.